Tozaro raises €8.1M Series A round
19 February 2024· Bedford, United Kingdom· health, biotech, ai, materials, b2b, deep_hardware
The funds will drive further commercialization of novel synthetic affinity reagents within the cell and gene therapy space and support recruitment efforts to expand in-house expertise.
Investors
LeadMercia Ventures
Also participating
Calculus Capital
About Tozaro
Stage
Series B
Headquarters
Bedford, United Kingdom
Founded
2015
Team Size
21–50
Sectors
healthbiotechaimaterialsb2bdeep_hardware